ɹˈɪtʃmən ɪz wˈʌn ʌvðə fˈaʊndɪŋ ˈɛdɪɾɚz ʌvðɪ ˌækədˈɛmɪk dʒˈɜːnəl ˌæntɪvˈaɪɚɹəl θˈɛɹəpi, ɐ kˈoʊfˈaʊndɚ ænd mˈɛmbɚɹ ʌvðə bˈoːɹd ʌv dᵻɹˈɛktɚz ʌvðɪ ˌɪntɚnˈæʃənəl ˌæntɪvˈaɪɚɹəl fˈɔːɹmɚli ˈeɪdz səsˈaɪəɾijˌuːˌɛsˈeɪ ˌaɪˌeɪˈɛsjˌuːˌɛsˈeɪ, ænd ˈɛdɪɾɚɹɪntʃˈiːf ʌv tˈɑːpɪks ɪn ˌæntɪvˈaɪɚɹəl mˈɛdəsən, æz wˈɛl æz hˌævɪŋ sˈɜːvd ɔnðɪ ˌɛdɪtˈoːɹɪəl bˈoːɹd ʌv fˈɪftiːn dʒˈɜːnəlz.
Richman is one of the founding editors of the academic journal Antiviral Therapy, a co-founder and member of the board of directors of the International Antiviral (formerly AIDS) Society-USA (IAS-USA), and editor-in-chief of Topics in Antiviral Medicine, as well as having served on the editorial board of 15 journals.